[BRIEFING.COM] The major averages continue to trade with decent gains as participation remains broad.
Eli Lilly (LLY 955.74, -33.38, -3.37%) is the worst-performing S&P 500 name after HSBC downgraded the stock to "Reduce" from "Hold" with a target price of $850. The weakness weighs on the health care sector (-0.1%), which otherwise trades mostly higher.
Meanwhile, Expedia Group (EXPE 244.83, +13.37, +5.78%) is among today's best performers, contributing to strength in the consumer discretionary sector (+1.1%), which benefits from strength across travel agency, cruise lines, and casino stocks.